Skip to main content

Danina Fisher

Equibles does not estimate personal net worth.

Get an email with a short summary when Hepion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get HEPA alerts

About Danina Fisher

Danina Fisher is recorded as Board Member at Hepion Pharmaceuticals, Inc. (HEPA) since July 1, 2026. Hepion Pharmaceuticals, Inc. reported in an 8-K filed July 2, 2026 that Danina Fisher was appointed directors of the Company, effective July 1, 2026. Hepion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Hepion Pharmaceuticals, Inc. includes Dr. Kaouthar Lbiati (CEO), Gary Stetz (CEO, CFO and Board Member), John Cavan (CEO and CFO) and 7 others.

“On July 1, 2026, the Board of Directors of Hepion Pharmaceuticals, Inc. (the "Company") approved the appointment of Danina Fisher and Gary S. Stetz, II as directors of the Company, effective immediately.”
Hepion Pharmaceuticals, Inc. Form 8-K, filed July 2, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Hepion Pharmaceuticals, Inc.

Recent activity